More articles from Cystic fibrosis

Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosis
Patricia Leutz-Schmidt, Daiva-Elzbieta Optazaite, Olaf Sommerburg, Monika Eichinger, Sabine Wege, Eva Steinke, Simon Y. Graeber, Michael U. Puderbach, Jens-Peter Schenk, Abdulsattar Alrajab, Simon M.F. Triphan, Hans-Ulrich Kauczor, Mirjam Stahl, Marcus A. Mall, Mark O. Wielpütz

ERJ Open Research Mar 2023, 9 (2) 00473-2022; DOI: 10.1183/23120541.00473-2022
High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing
Sacha Spelier, Eyleen de Poel, Georgia N. Ithakisiou, Sylvia W.F. Suen, Marne C. Hagemeijer, Danya Muilwijk, Annelotte M. Vonk, Jesse E. Brunsveld, Evelien Kruisselbrink, Cornelis K. van der Ent, Jeffrey M. Beekman

ERJ Open Research Jan 2023, 9 (1) 00495-2022; DOI: 10.1183/23120541.00495-2022
Nasal epithelial cell culture fluorescence recovery after photobleaching predicts cystic fibrosis therapeutic response
Timothy E. Corcoran, Carol A. Bertrand, Michael M. Myerburg, Daniel J. Weiner, Sheila A. Frizzell, Anna Li, Brittani Agostini, Robert S. Parker, Monica E. Shapiro, Ashok Muthukrishnan, Nicholas D. Hages, Brian P. Mulhern, Joseph M. Pilewski

ERJ Open Research Oct 2022, 8 (4) 00382-2022; DOI: 10.1183/23120541.00382-2022
Diagnostic agreement among experts assessing adults presenting with possible cystic fibrosis: need for improvement and implications for patient care
Alessandro N. Franciosi, April Tanzler, Jodi Goodwin, Pearce G. Wilcox, George M. Solomon, Albert Faro, Noel G. McElvaney, Damian G. Downey, Bradley S. Quon

ERJ Open Research Oct 2022, 8 (4) 00227-2022; DOI: 10.1183/23120541.00227-2022
Long-term effectiveness of dual CFTR modulator treatment of cystic fibrosis
Danya Muilwijk, Domenique D. Zomer-van Ommen, Vincent A.M. Gulmans, Marinus J.C. Eijkemans, Cornelis K. van der Ent, Dutch Cystic Fibrosis Registry (NCFR) Steering Group: , J. Altenburg, S.W.J. Terheggen-Lagro, H.G.M. Heijerman, K.M. de Winter-de Groot, M. Bakker, R.A.S. Hoek, H.M. Janssens, R. van der Meer, M. Nuijsink, H. van der Vaart, G.H. Koppelman, L.H. Conemans, M.A.G.E. Bannier, J.J. Noordhoek

ERJ Open Research Oct 2022, 8 (4) 00204-2022; DOI: 10.1183/23120541.00204-2022
The long-term effects of insulin use in incident cystic fibrosis-related diabetes: a target trial emulated using longitudinal national registry data
Emily Granger, Ruth H. Keogh, Freddy Frost

ERJ Open Research Oct 2022, 8 (4) 00170-2022; DOI: 10.1183/23120541.00170-2022
Novel CFTR modulator combinations maximise rescue of G85E and N1303K in rectal organoids
Marjolein M. Ensinck, Liesbeth De Keersmaecker, Anabela S. Ramalho, Senne Cuyx, Stephanie Van Biervliet, Lieven Dupont, Frauke Christ, Zeger Debyser, François Vermeulen, Marianne S. Carlon

ERJ Open Research Apr 2022, 8 (2) 00716-2021; DOI: 10.1183/23120541.00716-2021
CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011–2018
Emily E. Ricotta, D. Rebecca Prevots, Kenneth N. Olivier

ERJ Open Research Apr 2022, 8 (2) 00724-2021; DOI: 10.1183/23120541.00724-2021
Novel volumetric capnography indices measure ventilation inhomogeneity in cystic fibrosis
Sotirios Fouzas, Anne-Christianne Kentgens, Olga Lagiou, Bettina Sarah Frauchiger, Florian Wyler, Ilias Theodorakopoulos, Sophie Yammine, Philipp Latzin

ERJ Open Research Jan 2022, 8 (1) 00440-2021; DOI: 10.1183/23120541.00440-2021
Cross-talk of inflammatory mediators and airway epithelium reveals the cystic fibrosis transmembrane conductance regulator as a major target
Filipa B. Simões, Arthur Kmit, Margarida D. Amaral

ERJ Open Research Oct 2021, 7 (4) 00247-2021; DOI: 10.1183/23120541.00247-2021

Main menu

User menu

Search

More articles from Cystic fibrosis

Pages

Contact us